@article{11490,
  keywords = {Adolescent, Adult, Clofazimine, Dapsone, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, leprosy, Male, Middle Aged, Rifampin},
  author = {Katoch K and Ramu G and Ramanathan U and Sengupta U},
  title = {Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.},
  abstract = {<p>56 lepromatous leprosy patients with an initial average BI of 4.45 were administered once a month 600 mg of Rifampicin, 100 mg of Clofazimine on alternate days and 100 mg of Dapsone daily. None of these patients became smear negative in 2 years, and the same regimen was continued further. Two patients have become negative in 3 years and treatment has been stopped in them. The study indicates that highly bacilliferous LL/BL patients are likely to need 3 years or more of MDT for achieving bacterial negativity.</p>},
  year = {1987},
  journal = {Indian journal of leprosy},
  volume = {59},
  pages = {36-43},
  month = {1987 Jan-Mar},
  issn = {0254-9395},
  language = {eng},
}